Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PARECOXIB-AFT POWDER FOR SOLUTION FOR INJECTION 40MG

Approval Number

SIN17012P

Drug Name

PARECOXIB-AFT POWDER FOR SOLUTION FOR INJECTION 40MG

Product Name

PARECOXIB-AFT POWDER FOR SOLUTION FOR INJECTION 40MG

Approval Date

May 17, 2024

Registrant

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS, INTRAMUSCULAR

Medical Information

ATC Code

M01AH04

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

QILU PHARMACEUTICAL (HAINAN) CO., LTD.

Active Ingredients

Ingredient Name

Parecoxib Sodium eqv Parecoxib

Strength

40mg

Drug MonographParecoxib

Documents

Package Inserts

Parecoxib-AFT Powder for Solution for Injection PI.pdf

Approved: May 17, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy